Reported 2 days ago
Amgen Inc. (AMGN) is highlighted as a key player in the innovative healthcare space, expected to thrive through the growth of its pharmaceutical pipeline and significant market opportunities, including groundbreaking treatments for various conditions. As U.S. healthcare spending rises sharply, and with tariffs impacting production costs related to China, Amgen's diverse product offerings and advancements in drug development position it as a promising investment for 2025, despite expert opinions favoring AI stocks for potentially higher returns.
Source: YAHOO